• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PLL161407
Medical Device Problem Code Difficult to Open or Remove Packaging Material (2922)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 06/10/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
On (b)(6) 2024, the patient was treated for a zone 9 abdominal aortic aneurysm.During the procedure, the physician prepared a gore® excluder® aaa endoprosthesis for implant.Difficulty was experienced while attempting to remove the packaging mandrel from the device, and when it was finally removed, it also broke off part of the delivery catheter leading olive.This was not noticed by the physician, and the device was inserted into a gore® dryseal flex sheath.No unusual resistance was felt as the device was advanced into the sheath, but the sharp end of the broken leading olive cut the valve of the sheath, resulting in minor bleeding.Estimated blood loss was 100ml, no blood products given.The sheath was replaced, and the procedure was completed without further incident.The patient tolerated the procedure.The delivery catheter and mandrel will be returned for evaluation.The fsa had no information on the sheath, and it was discarded at the facility.
 
Additional Manufacturer Narrative
H.6.Type of investigation code b14: a review of the manufacturing records for this device verified the lot met all pre-release specifications.H.6.Type of investigation code b01: the evaluation of the returned device was able to confirm that the tip of the catheter leading olive was separated from the remainder of the leading olive which remained bonded to the guidewire lumen shaft.The cause of the tip of the leading olive breakage could not be determined with the currently available information; however, the reported difficulty removing the packaging material may have impacted how the physician gripped and pulled on the packaging mandrel and leading olive.H.6.Investigation conclusions code d15: there is insufficient information available for gore to reasonably draw conclusions related to aspects of the event, therefore conclusion code ¿d15: cause not established¿ is being used.Insufficient information may include limited or missing relevant medical records, involvement of multiple implanted devices (including non-gore devices) in the field of treatment, patient non-compliance, and/or a general lack of available detail or specificity related to an adverse event and/or device.H.6.Type of investigation updated code b21 to b01, b13, b14.H.6.Investigation findings updated code c21 to c070603 and c19.H.6.Investigation conclusions updated code d16 to d15.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
greg rawlings
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key19701854
Report Number3013164176-2024-02129
Device Sequence Number7719992
Product Code MIH
UDI-Device Identifier00733132618767
UDI-Public00733132618767
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/27/2026
Device Catalogue NumberPLL161407
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/10/2024
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date07/09/2024
Supplement Report FDA Received Date08/06/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/29/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age67 YR
Patient SexFemale
-
-